STOCK TITAN

[Form 4] Revolution Medicines, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., is offering $9.193 million of Contingent Income Auto-Callable Securities linked to the common stock of Amgen Inc. (AMGN). The notes are senior, unsecured obligations that mature on 29-Dec-2028 unless redeemed earlier. Each $1,000 security pays a quarterly contingent coupon of 2.625% (10.50% p.a.) when the closing price of AMGN on the relevant valuation date is at least 70 % of the initial share price ($279.11). Missed coupons may be fully ‘caught-up’ if the share price subsequently meets the threshold.

The notes may be automatically redeemed on any quarterly valuation date starting 26-Sep-2025 if AMGN closes at or above the initial share price. Holders then receive par plus the due coupon (including any unpaid coupons). If not redeemed, the principal repayment depends on AMGN’s final price:

  • ≥ 70 % of initial: return of principal plus final coupon (and unpaid coupons).
  • < 70 % of initial: principal is reduced 1-for-1 with the share decline, exposing investors to losses of up to 100 %.

Key economic terms include a downside threshold of $195.377, no exchange listing, CUSIP 17333LBW4, and a guaranteed but unsecured payment structure. The issue price is $1,000, while the estimated value is $971.50, reflecting structuring and distribution costs: an underwriting fee of $25, a $20 selling concession, and a $5 structuring fee to Morgan Stanley Wealth Management. Secondary market liquidity is expected to be limited and solely at Citigroup Global Markets Inc.’s discretion.

Risk highlights disclosed span full principal loss below threshold, contingent and non-cumulative coupons, early redemption limiting yield, issuer and guarantor credit risk, model-based valuation, potential conflicts in hedging, and complex U.S. tax treatment. The securities do not offer any participation in AMGN price appreciation or dividends. They are intended for sophisticated investors who can tolerate equity downside, credit exposure to Citigroup, and possible illiquidity.

Citigroup Global Markets Holdings Inc., garantita da Citigroup Inc., offre 9,193 milioni di dollari di Contingent Income Auto-Callable Securities legate alle azioni ordinarie di Amgen Inc. (AMGN). Le obbligazioni sono titoli senior, non garantiti, con scadenza il 29 dicembre 2028, salvo riscatto anticipato. Ogni titolo da 1.000 dollari paga un cedola trimestrale condizionata del 2,625% (10,50% annuo) se il prezzo di chiusura di AMGN nella data di valutazione rilevante è almeno il 70% del prezzo iniziale delle azioni (279,11 $). Le cedole non pagate possono essere recuperate integralmente se in seguito il prezzo raggiunge la soglia.

I titoli possono essere riscattati automaticamente in qualsiasi data di valutazione trimestrale a partire dal 26 settembre 2025, se AMGN chiude al prezzo iniziale o superiore. In tal caso, i detentori ricevono il valore nominale più la cedola dovuta (incluse eventuali cedole non pagate). Se non riscattati, il rimborso del capitale dipende dal prezzo finale di AMGN:

  • ≥ 70% del prezzo iniziale: rimborso del capitale più cedola finale (e cedole non pagate).
  • < 70% del prezzo iniziale: il capitale viene ridotto proporzionalmente alla perdita del titolo, esponendo gli investitori a perdite fino al 100%.

I termini economici chiave includono una soglia di ribasso di 195,377 $, nessuna quotazione in borsa, CUSIP 17333LBW4 e una struttura di pagamento garantita ma non garantita da pegno. Il prezzo di emissione è 1.000 $, mentre il valore stimato è 971,50 $, riflettendo costi di strutturazione e distribuzione: una commissione di sottoscrizione di 25 $, una concessione di vendita di 20 $ e una commissione di strutturazione di 5 $ a Morgan Stanley Wealth Management. La liquidità sul mercato secondario dovrebbe essere limitata e a discrezione esclusiva di Citigroup Global Markets Inc.

I rischi principali includono la perdita totale del capitale sotto la soglia, cedole condizionate e non cumulative, riscatto anticipato che limita il rendimento, rischio di credito dell’emittente e del garante, valutazione basata su modelli, potenziali conflitti nelle coperture e complessa tassazione statunitense. I titoli non offrono partecipazione all’apprezzamento del prezzo di AMGN né ai dividendi. Sono destinati a investitori sofisticati in grado di tollerare il rischio azionario, l’esposizione creditizia verso Citigroup e la possibile illiquidità.

Citigroup Global Markets Holdings Inc., garantizado por Citigroup Inc., ofrece 9.193 millones de dólares en Valores Contingentes de Ingreso Auto-Canjeables vinculados a las acciones ordinarias de Amgen Inc. (AMGN). Los bonos son obligaciones senior no garantizadas que vencen el 29 de diciembre de 2028, salvo que se rediman antes. Cada título de 1.000 dólares paga un cupón trimestral contingente del 2,625% (10,50% anual) cuando el precio de cierre de AMGN en la fecha de valoración correspondiente es al menos el 70% del precio inicial de la acción (279,11 $). Los cupones no pagados pueden recuperarse completamente si el precio de la acción posteriormente alcanza el umbral.

Los bonos pueden ser redimidos automáticamente en cualquier fecha de valoración trimestral a partir del 26 de septiembre de 2025 si AMGN cierra en o por encima del precio inicial. En ese caso, los tenedores reciben el valor nominal más el cupón debido (incluidos los cupones impagos). Si no se redimen, el reembolso del principal depende del precio final de AMGN:

  • ≥ 70% del precio inicial: devolución del principal más cupón final (y cupones impagos).
  • < 70% del precio inicial: el principal se reduce en proporción a la caída de la acción, exponiendo a los inversores a pérdidas de hasta el 100%.

Los términos económicos clave incluyen un umbral a la baja de 195,377 $, sin cotización en bolsa, CUSIP 17333LBW4 y una estructura de pago garantizada pero no asegurada. El precio de emisión es de 1.000 $, mientras que el valor estimado es de 971,50 $, reflejando costos de estructuración y distribución: una comisión de suscripción de 25 $, una concesión de venta de 20 $ y una comisión de estructuración de 5 $ para Morgan Stanley Wealth Management. Se espera que la liquidez en el mercado secundario sea limitada y exclusivamente a discreción de Citigroup Global Markets Inc.

Los riesgos destacados incluyen la pérdida total del principal por debajo del umbral, cupones contingentes y no acumulativos, redención anticipada que limita el rendimiento, riesgo crediticio del emisor y garante, valoración basada en modelos, posibles conflictos en la cobertura y tratamiento fiscal estadounidense complejo. Los valores no ofrecen participación en la apreciación del precio de AMGN ni en dividendos. Están destinados a inversores sofisticados que pueden tolerar la caída del valor de las acciones, la exposición crediticia a Citigroup y la posible iliquidez.

Citigroup Global Markets Holdings Inc.는 Citigroup Inc.가 보증하며, Amgen Inc. (AMGN) 보통주에 연계된 9,193만 달러 규모의 조건부 수익 자동 상환 증권을 제공합니다. 이 증권은 선순위 무담보 채무로, 2028년 12월 29일에 만기되며 조기 상환되지 않는 한 만기일까지 유지됩니다. 각 1,000달러 증권은 해당 평가일에 AMGN 종가가 최초 주가의 70% 이상 (279.11달러)일 경우 분기별 조건부 쿠폰 2.625% (연 10.50%)를 지급합니다. 미지급 쿠폰은 이후 주가가 기준을 충족하면 전액 지급될 수 있습니다.

이 증권은 2025년 9월 26일부터 시작하는 분기 평가일에 AMGN 종가가 최초 주가 이상일 경우 자동 상환될 수 있습니다. 상환 시 투자자는 원금과 미지급 쿠폰을 포함한 해당 쿠폰을 받습니다. 상환되지 않을 경우 원금 상환은 AMGN 최종 가격에 따라 결정됩니다:

  • 최초가의 70% 이상: 원금과 최종 쿠폰(미지급 쿠폰 포함) 지급.
  • 최초가의 70% 미만: 주가 하락에 따라 원금이 1대1로 감소하여 투자자는 최대 100% 손실 위험에 노출됩니다.

주요 경제 조건으로는 하락 기준선 195.377달러, 상장 없음, CUSIP 17333LBW4, 보증되었으나 무담보인 지급 구조가 포함됩니다. 발행가는 1,000달러이며, 추정 가치는 971.50달러로 구조화 및 유통 비용(인수 수수료 25달러, 판매 수수료 20달러, Morgan Stanley Wealth Management에 대한 구조화 수수료 5달러)을 반영합니다. 2차 시장 유동성은 제한적이며 Citigroup Global Markets Inc.의 재량에 따릅니다.

주요 위험 사항으로는 기준선 이하에서 원금 전액 손실 가능성, 조건부 및 비누적 쿠폰, 조기 상환으로 인한 수익 제한, 발행자 및 보증인 신용 위험, 모델 기반 평가, 헤지 시 잠재적 이해상충, 복잡한 미국 세금 처리 등이 있습니다. 이 증권은 AMGN 주가 상승이나 배당에 대한 참여를 제공하지 않으며, 주식 하락 위험, Citigroup에 대한 신용 노출, 그리고 유동성 부족 가능성을 감수할 수 있는 전문 투자자를 대상으로 합니다.

Citigroup Global Markets Holdings Inc., garanti par Citigroup Inc., propose 9,193 millions de dollars de titres à revenu conditionnel auto-remboursables liés aux actions ordinaires de Amgen Inc. (AMGN). Les obligations sont des titres senior non garantis arrivant à échéance le 29 décembre 2028, sauf remboursement anticipé. Chaque titre de 1 000 $ verse un coupon trimestriel conditionnel de 2,625 % (10,50 % par an) lorsque le cours de clôture d'AMGN à la date d'évaluation pertinente est au moins égal à 70 % du prix initial de l'action (279,11 $). Les coupons manqués peuvent être entièrement rattrapés si le cours atteint ultérieurement ce seuil.

Les titres peuvent être remboursés automatiquement à toute date d'évaluation trimestrielle à partir du 26 septembre 2025 si AMGN clôture au prix initial ou au-dessus. Les détenteurs reçoivent alors le pair plus le coupon dû (y compris les coupons impayés). En cas de non-remboursement, le remboursement du capital dépend du prix final d’AMGN :

  • ≥ 70 % du prix initial : remboursement du capital plus coupon final (et coupons impayés).
  • < 70 % du prix initial : le capital est réduit à hauteur de la baisse de l’action, exposant les investisseurs à une perte pouvant atteindre 100 %.

Les conditions économiques clés comprennent un seuil de baisse à 195,377 $, pas de cotation en bourse, CUSIP 17333LBW4, et une structure de paiement garantie mais non sécurisée. Le prix d’émission est de 1 000 $, tandis que la valeur estimée est de 971,50 $, reflétant les coûts de structuration et de distribution : une commission de souscription de 25 $, une concession de vente de 20 $ et une commission de structuration de 5 $ versée à Morgan Stanley Wealth Management. La liquidité sur le marché secondaire devrait être limitée et à la discrétion exclusive de Citigroup Global Markets Inc.

Les risques principaux comprennent la perte totale du capital sous le seuil, des coupons conditionnels et non cumulatifs, un remboursement anticipé limitant le rendement, le risque de crédit de l’émetteur et du garant, une valorisation basée sur des modèles, des conflits potentiels dans la couverture, ainsi qu’une fiscalité américaine complexe. Ces titres ne donnent aucune participation à l’appréciation du cours d’AMGN ni aux dividendes. Ils sont destinés à des investisseurs avertis capables de supporter le risque de baisse des actions, l’exposition au crédit de Citigroup et une possible illiquidité.

Citigroup Global Markets Holdings Inc., garantiert durch Citigroup Inc., bietet 9,193 Millionen US-Dollar an Contingent Income Auto-Callable Securities an, die mit den Stammaktien von Amgen Inc. (AMGN) verknüpft sind. Die Schuldverschreibungen sind vorrangige, unbesicherte Verbindlichkeiten mit Fälligkeit am 29. Dezember 2028, sofern sie nicht früher zurückgezahlt werden. Jede 1.000-Dollar-Anleihe zahlt eine vierteljährliche bedingte Kuponrate von 2,625% (10,50% p.a.), wenn der Schlusskurs von AMGN am jeweiligen Bewertungstag mindestens 70 % des Anfangskurses (279,11 $) beträgt. Ausgefallene Kupons können vollständig nachgezahlt werden, falls der Aktienkurs später die Schwelle erreicht.

Die Anleihen können ab dem 26. September 2025 an jedem vierteljährlichen Bewertungstag automatisch zurückgezahlt werden, wenn AMGN zum oder über dem Anfangskurs schließt. Die Inhaber erhalten dann den Nennwert plus den fälligen Kupon (einschließlich etwaiger ausstehender Kupons). Wenn nicht zurückgezahlt, hängt die Rückzahlung des Kapitals vom Schlusskurs von AMGN ab:

  • ≥ 70 % des Anfangskurses: Rückzahlung des Kapitals plus finaler Kupon (und ausstehende Kupons).
  • < 70 % des Anfangskurses: Das Kapital wird 1:1 mit dem Kursverlust reduziert, wodurch Anleger einem Verlust von bis zu 100 % ausgesetzt sind.

Wichtige wirtschaftliche Bedingungen umfassen eine Abwärtsgrenze von 195,377 $, keine Börsennotierung, CUSIP 17333LBW4 und eine garantierte, jedoch unbesicherte Zahlungsstruktur. Der Ausgabepreis beträgt 1.000 $, während der geschätzte Wert 971,50 $ beträgt, was Strukturierungs- und Vertriebskosten widerspiegelt: eine Zeichnungsgebühr von 25 $, eine Verkaufsprovision von 20 $ und eine Strukturierungsgebühr von 5 $ an Morgan Stanley Wealth Management. Die Liquidität am Sekundärmarkt wird voraussichtlich begrenzt sein und liegt ausschließlich im Ermessen von Citigroup Global Markets Inc.

Risiko-Hinweise umfassen den vollständigen Kapitalverlust unterhalb der Schwelle, bedingte und nicht kumulative Kupons, vorzeitige Rückzahlung, die die Rendite begrenzt, Emittenten- und Garantiegeber-Kreditrisiko, modellbasierte Bewertung, potenzielle Interessenkonflikte bei der Absicherung sowie komplexe US-Steuerregelungen. Die Wertpapiere bieten keine Beteiligung an Kurssteigerungen oder Dividenden von AMGN. Sie sind für erfahrene Anleger gedacht, die Kursverluste, Kreditrisiken von Citigroup und mögliche Illiquidität tolerieren können.

Positive
  • High contingent coupon: 10.50% annual rate, with missed coupons recoverable if AMGN subsequently meets the threshold.
  • 30% downside buffer: Principal is protected unless AMGN falls more than 30% from the initial price.
  • Early autocall feature: Potential for rapid return of capital plus coupon if AMGN stays flat or appreciates.
  • Citigroup guarantee: Payments are fully and unconditionally guaranteed by Citigroup Inc.
Negative
  • Principal at risk: Investors may lose up to 100% of principal if AMGN closes below the 70% threshold at maturity.
  • No upside participation: Returns capped at coupon income; stock appreciation beyond 0% triggers early call.
  • Limited liquidity: Unlisted security; secondary market making is discretionary and may cease.
  • Credit exposure: Depends on the unsecured credit of Citigroup Global Markets Holdings Inc. and Citigroup Inc.
  • Issue price premium: Estimated value of $971.50 is 2.85% below the $1,000 offer, reflecting fees and structuring costs.
  • Complex, uncertain tax treatment: Prepaid-forward classification and possible 30% withholding for non-U.S. holders.

Insights

TL;DR: High 10.5% coupon and 30% buffer attractive, but value erosion, early call and full downside make the note suitable only for yield-seeking risk-takers.

The note packages a rich headline yield with a standard 70% barrier and quarterly autocall. Investors gain a catch-up feature that restores skipped coupons, enhancing effective yield if AMGN oscillates around the barrier. However, the $971.50 estimated value versus the $1,000 offer price signals an immediate 2.85% mark-to-market drag, and secondary liquidity rests solely with the underwriter. Economic upside caps at coupon receipts; any AMGN rally beyond 0% triggers an early call, truncating income potential. On the downside, exposure is linear once the 30% buffer is breached, identical to holding the stock below that level yet without dividend rights. Position sizing should reflect the double-layer credit risk (CGMHI & Citigroup Inc.) and the possibility of zero recovery in a severe AMGN drawdown.

TL;DR: Principal-at-risk note adds Citigroup credit exposure and model risk; limited liquidity and sub-par fair value skew risk-reward negatively.

From a risk perspective, buyers exchange unsecured credit exposure for above-market coupons. The documentation underscores that payments depend on Citigroup’s solvency; a downgrade or spread widening could impair secondary prices even with AMGN stable. The lack of exchange listing, discretionary market-making and a three-month temporary price premium imply potential exit discounts well below intrinsic value. Furthermore, valuation relies on proprietary models calibrated with an internal funding rate, creating opacity for investors. Tax treatment is uncertain—coupon income is ordinary, and non-U.S. holders face 30% withholding. Combining equity tail risk, credit risk and liquidity risk for a gross yield of 10.5% appears uncompelling for conservative portfolios.

Citigroup Global Markets Holdings Inc., garantita da Citigroup Inc., offre 9,193 milioni di dollari di Contingent Income Auto-Callable Securities legate alle azioni ordinarie di Amgen Inc. (AMGN). Le obbligazioni sono titoli senior, non garantiti, con scadenza il 29 dicembre 2028, salvo riscatto anticipato. Ogni titolo da 1.000 dollari paga un cedola trimestrale condizionata del 2,625% (10,50% annuo) se il prezzo di chiusura di AMGN nella data di valutazione rilevante è almeno il 70% del prezzo iniziale delle azioni (279,11 $). Le cedole non pagate possono essere recuperate integralmente se in seguito il prezzo raggiunge la soglia.

I titoli possono essere riscattati automaticamente in qualsiasi data di valutazione trimestrale a partire dal 26 settembre 2025, se AMGN chiude al prezzo iniziale o superiore. In tal caso, i detentori ricevono il valore nominale più la cedola dovuta (incluse eventuali cedole non pagate). Se non riscattati, il rimborso del capitale dipende dal prezzo finale di AMGN:

  • ≥ 70% del prezzo iniziale: rimborso del capitale più cedola finale (e cedole non pagate).
  • < 70% del prezzo iniziale: il capitale viene ridotto proporzionalmente alla perdita del titolo, esponendo gli investitori a perdite fino al 100%.

I termini economici chiave includono una soglia di ribasso di 195,377 $, nessuna quotazione in borsa, CUSIP 17333LBW4 e una struttura di pagamento garantita ma non garantita da pegno. Il prezzo di emissione è 1.000 $, mentre il valore stimato è 971,50 $, riflettendo costi di strutturazione e distribuzione: una commissione di sottoscrizione di 25 $, una concessione di vendita di 20 $ e una commissione di strutturazione di 5 $ a Morgan Stanley Wealth Management. La liquidità sul mercato secondario dovrebbe essere limitata e a discrezione esclusiva di Citigroup Global Markets Inc.

I rischi principali includono la perdita totale del capitale sotto la soglia, cedole condizionate e non cumulative, riscatto anticipato che limita il rendimento, rischio di credito dell’emittente e del garante, valutazione basata su modelli, potenziali conflitti nelle coperture e complessa tassazione statunitense. I titoli non offrono partecipazione all’apprezzamento del prezzo di AMGN né ai dividendi. Sono destinati a investitori sofisticati in grado di tollerare il rischio azionario, l’esposizione creditizia verso Citigroup e la possibile illiquidità.

Citigroup Global Markets Holdings Inc., garantizado por Citigroup Inc., ofrece 9.193 millones de dólares en Valores Contingentes de Ingreso Auto-Canjeables vinculados a las acciones ordinarias de Amgen Inc. (AMGN). Los bonos son obligaciones senior no garantizadas que vencen el 29 de diciembre de 2028, salvo que se rediman antes. Cada título de 1.000 dólares paga un cupón trimestral contingente del 2,625% (10,50% anual) cuando el precio de cierre de AMGN en la fecha de valoración correspondiente es al menos el 70% del precio inicial de la acción (279,11 $). Los cupones no pagados pueden recuperarse completamente si el precio de la acción posteriormente alcanza el umbral.

Los bonos pueden ser redimidos automáticamente en cualquier fecha de valoración trimestral a partir del 26 de septiembre de 2025 si AMGN cierra en o por encima del precio inicial. En ese caso, los tenedores reciben el valor nominal más el cupón debido (incluidos los cupones impagos). Si no se redimen, el reembolso del principal depende del precio final de AMGN:

  • ≥ 70% del precio inicial: devolución del principal más cupón final (y cupones impagos).
  • < 70% del precio inicial: el principal se reduce en proporción a la caída de la acción, exponiendo a los inversores a pérdidas de hasta el 100%.

Los términos económicos clave incluyen un umbral a la baja de 195,377 $, sin cotización en bolsa, CUSIP 17333LBW4 y una estructura de pago garantizada pero no asegurada. El precio de emisión es de 1.000 $, mientras que el valor estimado es de 971,50 $, reflejando costos de estructuración y distribución: una comisión de suscripción de 25 $, una concesión de venta de 20 $ y una comisión de estructuración de 5 $ para Morgan Stanley Wealth Management. Se espera que la liquidez en el mercado secundario sea limitada y exclusivamente a discreción de Citigroup Global Markets Inc.

Los riesgos destacados incluyen la pérdida total del principal por debajo del umbral, cupones contingentes y no acumulativos, redención anticipada que limita el rendimiento, riesgo crediticio del emisor y garante, valoración basada en modelos, posibles conflictos en la cobertura y tratamiento fiscal estadounidense complejo. Los valores no ofrecen participación en la apreciación del precio de AMGN ni en dividendos. Están destinados a inversores sofisticados que pueden tolerar la caída del valor de las acciones, la exposición crediticia a Citigroup y la posible iliquidez.

Citigroup Global Markets Holdings Inc.는 Citigroup Inc.가 보증하며, Amgen Inc. (AMGN) 보통주에 연계된 9,193만 달러 규모의 조건부 수익 자동 상환 증권을 제공합니다. 이 증권은 선순위 무담보 채무로, 2028년 12월 29일에 만기되며 조기 상환되지 않는 한 만기일까지 유지됩니다. 각 1,000달러 증권은 해당 평가일에 AMGN 종가가 최초 주가의 70% 이상 (279.11달러)일 경우 분기별 조건부 쿠폰 2.625% (연 10.50%)를 지급합니다. 미지급 쿠폰은 이후 주가가 기준을 충족하면 전액 지급될 수 있습니다.

이 증권은 2025년 9월 26일부터 시작하는 분기 평가일에 AMGN 종가가 최초 주가 이상일 경우 자동 상환될 수 있습니다. 상환 시 투자자는 원금과 미지급 쿠폰을 포함한 해당 쿠폰을 받습니다. 상환되지 않을 경우 원금 상환은 AMGN 최종 가격에 따라 결정됩니다:

  • 최초가의 70% 이상: 원금과 최종 쿠폰(미지급 쿠폰 포함) 지급.
  • 최초가의 70% 미만: 주가 하락에 따라 원금이 1대1로 감소하여 투자자는 최대 100% 손실 위험에 노출됩니다.

주요 경제 조건으로는 하락 기준선 195.377달러, 상장 없음, CUSIP 17333LBW4, 보증되었으나 무담보인 지급 구조가 포함됩니다. 발행가는 1,000달러이며, 추정 가치는 971.50달러로 구조화 및 유통 비용(인수 수수료 25달러, 판매 수수료 20달러, Morgan Stanley Wealth Management에 대한 구조화 수수료 5달러)을 반영합니다. 2차 시장 유동성은 제한적이며 Citigroup Global Markets Inc.의 재량에 따릅니다.

주요 위험 사항으로는 기준선 이하에서 원금 전액 손실 가능성, 조건부 및 비누적 쿠폰, 조기 상환으로 인한 수익 제한, 발행자 및 보증인 신용 위험, 모델 기반 평가, 헤지 시 잠재적 이해상충, 복잡한 미국 세금 처리 등이 있습니다. 이 증권은 AMGN 주가 상승이나 배당에 대한 참여를 제공하지 않으며, 주식 하락 위험, Citigroup에 대한 신용 노출, 그리고 유동성 부족 가능성을 감수할 수 있는 전문 투자자를 대상으로 합니다.

Citigroup Global Markets Holdings Inc., garanti par Citigroup Inc., propose 9,193 millions de dollars de titres à revenu conditionnel auto-remboursables liés aux actions ordinaires de Amgen Inc. (AMGN). Les obligations sont des titres senior non garantis arrivant à échéance le 29 décembre 2028, sauf remboursement anticipé. Chaque titre de 1 000 $ verse un coupon trimestriel conditionnel de 2,625 % (10,50 % par an) lorsque le cours de clôture d'AMGN à la date d'évaluation pertinente est au moins égal à 70 % du prix initial de l'action (279,11 $). Les coupons manqués peuvent être entièrement rattrapés si le cours atteint ultérieurement ce seuil.

Les titres peuvent être remboursés automatiquement à toute date d'évaluation trimestrielle à partir du 26 septembre 2025 si AMGN clôture au prix initial ou au-dessus. Les détenteurs reçoivent alors le pair plus le coupon dû (y compris les coupons impayés). En cas de non-remboursement, le remboursement du capital dépend du prix final d’AMGN :

  • ≥ 70 % du prix initial : remboursement du capital plus coupon final (et coupons impayés).
  • < 70 % du prix initial : le capital est réduit à hauteur de la baisse de l’action, exposant les investisseurs à une perte pouvant atteindre 100 %.

Les conditions économiques clés comprennent un seuil de baisse à 195,377 $, pas de cotation en bourse, CUSIP 17333LBW4, et une structure de paiement garantie mais non sécurisée. Le prix d’émission est de 1 000 $, tandis que la valeur estimée est de 971,50 $, reflétant les coûts de structuration et de distribution : une commission de souscription de 25 $, une concession de vente de 20 $ et une commission de structuration de 5 $ versée à Morgan Stanley Wealth Management. La liquidité sur le marché secondaire devrait être limitée et à la discrétion exclusive de Citigroup Global Markets Inc.

Les risques principaux comprennent la perte totale du capital sous le seuil, des coupons conditionnels et non cumulatifs, un remboursement anticipé limitant le rendement, le risque de crédit de l’émetteur et du garant, une valorisation basée sur des modèles, des conflits potentiels dans la couverture, ainsi qu’une fiscalité américaine complexe. Ces titres ne donnent aucune participation à l’appréciation du cours d’AMGN ni aux dividendes. Ils sont destinés à des investisseurs avertis capables de supporter le risque de baisse des actions, l’exposition au crédit de Citigroup et une possible illiquidité.

Citigroup Global Markets Holdings Inc., garantiert durch Citigroup Inc., bietet 9,193 Millionen US-Dollar an Contingent Income Auto-Callable Securities an, die mit den Stammaktien von Amgen Inc. (AMGN) verknüpft sind. Die Schuldverschreibungen sind vorrangige, unbesicherte Verbindlichkeiten mit Fälligkeit am 29. Dezember 2028, sofern sie nicht früher zurückgezahlt werden. Jede 1.000-Dollar-Anleihe zahlt eine vierteljährliche bedingte Kuponrate von 2,625% (10,50% p.a.), wenn der Schlusskurs von AMGN am jeweiligen Bewertungstag mindestens 70 % des Anfangskurses (279,11 $) beträgt. Ausgefallene Kupons können vollständig nachgezahlt werden, falls der Aktienkurs später die Schwelle erreicht.

Die Anleihen können ab dem 26. September 2025 an jedem vierteljährlichen Bewertungstag automatisch zurückgezahlt werden, wenn AMGN zum oder über dem Anfangskurs schließt. Die Inhaber erhalten dann den Nennwert plus den fälligen Kupon (einschließlich etwaiger ausstehender Kupons). Wenn nicht zurückgezahlt, hängt die Rückzahlung des Kapitals vom Schlusskurs von AMGN ab:

  • ≥ 70 % des Anfangskurses: Rückzahlung des Kapitals plus finaler Kupon (und ausstehende Kupons).
  • < 70 % des Anfangskurses: Das Kapital wird 1:1 mit dem Kursverlust reduziert, wodurch Anleger einem Verlust von bis zu 100 % ausgesetzt sind.

Wichtige wirtschaftliche Bedingungen umfassen eine Abwärtsgrenze von 195,377 $, keine Börsennotierung, CUSIP 17333LBW4 und eine garantierte, jedoch unbesicherte Zahlungsstruktur. Der Ausgabepreis beträgt 1.000 $, während der geschätzte Wert 971,50 $ beträgt, was Strukturierungs- und Vertriebskosten widerspiegelt: eine Zeichnungsgebühr von 25 $, eine Verkaufsprovision von 20 $ und eine Strukturierungsgebühr von 5 $ an Morgan Stanley Wealth Management. Die Liquidität am Sekundärmarkt wird voraussichtlich begrenzt sein und liegt ausschließlich im Ermessen von Citigroup Global Markets Inc.

Risiko-Hinweise umfassen den vollständigen Kapitalverlust unterhalb der Schwelle, bedingte und nicht kumulative Kupons, vorzeitige Rückzahlung, die die Rendite begrenzt, Emittenten- und Garantiegeber-Kreditrisiko, modellbasierte Bewertung, potenzielle Interessenkonflikte bei der Absicherung sowie komplexe US-Steuerregelungen. Die Wertpapiere bieten keine Beteiligung an Kurssteigerungen oder Dividenden von AMGN. Sie sind für erfahrene Anleger gedacht, die Kursverluste, Kreditrisiken von Citigroup und mögliche Illiquidität tolerieren können.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Clyburn Frank

(Last) (First) (Middle)
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DR

(Street)
REDWOOD CITY CA 94063

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Revolution Medicines, Inc. [ RVMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/26/2025 A 2,806 A $0 9,738(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $37.48 06/26/2025 A 10,337 (2) 06/26/2035 Common Stock 10,337 $0 10,337 D
Explanation of Responses:
1. Includes 8,005 Restricted Stock Units.
2. Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
/s/ Jack Anders, as Attorney-in-fact for Frank Clyburn 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What is the coupon rate on Citigroup’s 2025 AMGN-linked contingent income securities (CUSIP 17333LBW4)?

The notes pay a 2.625% quarterly coupon, equivalent to 10.50% per annum, when AMGN closes at or above 70% of its initial price.

When can the securities be automatically redeemed by Citigroup (symbol C)?

Starting 26-Sep-2025 and on each subsequent valuation date, the notes are redeemed if AMGN’s closing price is at least the $279.11 initial price.

What happens at maturity if Amgen stock falls below 70% of the initial price?

Holders receive $1,000 plus $1,000 × (Final Price − Initial Price) / Initial Price, potentially less than $700 or even zero, and no coupon.

How does the estimated value compare with the $1,000 issue price?

Citigroup’s model-based estimated value is $971.50, reflecting underwriting, hedging and structuring costs embedded in the offer price.

Are the notes listed on an exchange or tradeable in liquid markets?

No. The securities will not be listed; any secondary liquidity is provided solely at Citigroup Global Markets Inc.’s discretion.

Do investors receive Amgen dividends through this product?

No. Holders do not receive dividends or any other shareholder rights associated with Amgen common stock.
Revolution Medicines, Inc.

NASDAQ:RVMD

RVMD Rankings

RVMD Latest News

RVMD Latest SEC Filings

RVMD Stock Data

6.98B
181.51M
2.06%
106.38%
8.52%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
REDWOOD CITY